Simvastatin

1. When dietary therapy and other non-drug treatments for hypercholesterolemia are ineffective, simvastatin can be used to reduce total cholesterol and low-density lipoprotein cholesterol in patients with primary hypercholesterolemia. Simvastatin can also increase high-density lipoprotein cholesterol and thus reduce the ratio of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol. In patients with combined hypercholesterolemia and hypertriglyceridemia, when hypercholesterolemia is the main abnormality, it can reduce elevated cholesterol levels; 2. For patients with coronary heart disease, simvastatin is suitable for: reducing the risk of death; reducing the risk of death from coronary heart disease and non-fatal myocardial infarction; reducing myocardial revascularization surgery (coronary artery bypass grafting and percutaneous balloon coronary angioplasty); delaying the progression of atherosclerosis, including the occurrence of new lesions and total blockage.

1. It is contraindicated for those who are allergic to any component of this product; 2. It is contraindicated for those with active hepatitis or unexplained persistent elevation of serum transaminase; 3. It is contraindicated for those who are pregnant and should be used with caution by lactating women; 4. It should be used with caution in children.

Precautions for children: Use with caution in children. Precautions for pregnancy and lactation: 1. Pregnant women are prohibited from using this product; 2. Use with caution in lactating women.

Wichita, Its Group of Pharmaceutical Co., Ltd.

• Founded in:

  2002-09-30

• Address:

  Datong Economic and Technological Development Zone, Pharmaceutical Industrial Park, High-tech Industrial Park

• Tax NO.:

  91140200734026330J

• Registered Funds:

  1120.37123441 million yuan

• Website:

  Log in to view

• Email:

  Log in to view